Search
  • 網站搜尋
亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。
返回搜索結果

Hydrogel Formulations That Induce Dormancy in Breast Cancer Cells


詳細技術說明

TechnologyDescription:Dr. Slater’s lab at the University of Delaware has developeda hydrogel formulation that allow long-term culture of cancer cells duringwhich the cells can be maintained in a dormant or quiescent state or in anactively proliferating state. The process is facile, easily replicable, andamenable to high-throughput assays, for both assessment of cellularcharacteristics and drug validation.Background &Applications:Metastasis isresponsible for 90% of cancer-associated mortality. Metastasized cells oftenlay in a dormant state for years, or even decades, before reverting to anactively proliferating state to form secondary tumors. Current cancertreatments do not treat dormant cells. Accordingly, there is much interest indeveloping therapeutics that treat dormant cancer cells but inducing dormancyand monitoring dormant cells in animal models in currently impossible. Toovercome this problem, we developed a tissue-engineered, in vitro platformthat allows us to induce both dormant and proliferative states in highlymetastatic breast cancer cells via tuning of the matrix properties. We envisiontwo main applications of this platform:·      Screening the efficacy of new therapeutics on treatmentof dormant cancer cells. ·      Development of new therapeutic targets to treat dormantcells.ProblemsAddressed:Most current invitro models of breast cancer recapitulate the metastatic and aggressivebehavior of cancer cells but not the dormant state associated with metastases.Current chemotherapeutics are effective in treating proliferating cells but donot dormant cells. Methods to induce a desired state (proliferative or dormant)in cancer cells still lacking. In the absence of such models, molecularcharacterization of dormant tumor cells is also challenging. This platformfacilitates discovery of both novel targets specific to dormant cancer cellsand validation of potential drug candidates against identified targets forfuture translation.


國家

United States


申請號碼

Patent Pending


國家/地區

美國

欲了解更多信息,請點擊 這裡
Business of IP Asia Forum
桌面版